Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Male

Explore clinical trials studying Genital Diseases, Male. Study availability and eligibility vary by location and protocol.

6,750 public trials 1,242 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Male trial results

Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

NCT06931340

Conditions
Castration-Sensitive Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
View all 195 locations
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

NCT07200830

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View all 102 locations
View Trial Details
Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

NCT07140900

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

Distance-Based Exercise to Preserve Function and Prevent Disability

NCT07059884

Conditions
Adnexal Diseases, Anal Cancer, Anus Diseases, +82 more
Locations
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
  • Kaiser Permanente Fresno Orchard Plaza Fresno, California, United States
  • Kaiser Permanente-Modesto Modesto, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329

Conditions
Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +33 more
Locations
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Cancer Care Wollongong Wollongong, New South Wales, Australia
View Trial Details
Recruiting

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

NCT07611110

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Research Site Dothan, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
View all 104 locations
View Trial Details
Recruiting

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

NCT07483658

Conditions
Biochemical Recurrence of Malignant Neoplasm of Prostate, Digestive System Diseases, Female Urogenital Diseases, +22 more
Locations
  • Gatineau Hospital Gatineau, Quebec, Canada
  • Hôpital Général Juif Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
  • CHU de Québec-Université Laval Québec, Quebec, Canada
View Trial Details

Related conditions